Around 50–80% of RA patients’ sera have been found to be ACPA-positive [6,7], and these individuals experience a more severe disease compared to RA patients, whose sera have been found to be negative for these antibodies [1,8]. Here, PRTN3 is linked to rheumatoid arthritis.